Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs

Veterinary Microbiology

Volumn 146, Issue 1-2, 2010, Pages 161-166

  Gibson, Justine S ^a   Cobbold, Rowland N ^a   Kyaw Tanner, Myat T ^a   Heisig, Peter ^b   Trott, Darren J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Dogs; Escherichia coli; Fluoroquinolones; Multidrug resistance

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACRR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; DOG; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE MUTATION; GYRA GENE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PARC GENE; QEPA GENE; QNRA1 GENE; QNRB2 GENE; QNRS1 GENE;

ANIMALS; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

ANIMALIA; CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 78049248890     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.04.012     Document Type: Article

References (21)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 2007, 60:394-397.
3. KPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob. Agents Chemother. 2008, 52:2962-2965.
4. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard - Third Edition. CLSI document M31-A3 2008, Clinical and Laboratory Standards Institute, Wayne, PA.
5. Gibson J.S., Cobbold R.N., Heisig P., Sidjabat H.E., Kyaw-Tanner M.T., Trott D.J. Identification of Qnr and AAC(6′)-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals. Vet. Microbiol. 2009, 10.1016/j.vetmic.2009.11.031.
6. Gibson J.S., Cobbold R.N., Trott D.J. Characterization of multidrug-resistant Escherichia coli isolated from extraintestinal clinical infections in animals. J. Med. Microbiol. 2010, 59:592-598.
7. Hopkins K.L., Davies R.H., Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 2005, 25:358-373.
8. Kern W.V., Steinke P., Schumacher A., Schuster S., von Baum H., Bohnert J.A. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 2006, 57:339-343.
9. Komp Lindgren P., Karlsson A., Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 2003, 47:3222-3232.
10. Ma J., Zeng Z., Chen Z., Xu X., Wang X., Deng Y., Lu D., Huang L., Zhang Y., Liu J., Wang M. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob. Agents Chemother. 2008, 53:519-524.
11. Martinez-Martinez L., Pascual A., Garcia I., Tran J., Jacoby G.A. Interaction of plasmid and host quinolone resistance. J. Antimicrob. Chemother. 2003, 51:1037-1039.
12. Oethinger M., Kern W.V., Jellen-Ritter A.S., McMurry L.M., Levy S.B. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 2000, 44:10-13.
13. Oethinger M., Podglajen I., Kern W.V., Levy S.B. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 1998, 42:2089-2094.
14. Oram M., Fisher L.M. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 1991, 35:387-389.
15. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 2006, 50:3953-3955.
16. Pomba C., da Fonseca J.D., Baptista B.C., Correia J.D., Martinez-Martinez L. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6′)-Ib-cr genes in a dog. Antimicrob. Agents Chemother. 2009, 53:327-328.
17. Saenz Y., Brinas L., Dominguez E., Ruiz J., Zarazaga M., Vila J., Torres C. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob. Agents Chemother. 2004, 48:3996-4001.
18. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 2009, 22:664-689.
19. Wang H., Dzink-Fox J.L., Chen M., Levy S.B. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 2001, 45:1515-1521.
20. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 2003, 47:2242-2248.
21. Yamane K., Wachino J., Suzuki S., Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 2008, 52:1564-1566.